Ribosome display and selection of human anti-CD22 scFvs derived from an acute lymphocytic leukemia patient

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Biological chemistry

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1515/BC.2008.045PMID 18225987
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Eukaryotic ribosome display with in situ DNA recovery

  2007cited by this paper
• Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target

  2007cited by this paper
• Ribosome display for improved biotherapeutic molecules

  2006cited by this paper
• Identification of a functional nuclear export signal in the green fluorescent protein asFP499.

  2006cited by this paper
• Engineering of the Escherichia coli Im7 immunity protein as a loop display scaffold.

  2006cited by this paper
• Ribosome display of antibodies: expression, specificity and recovery in a eukaryotic system.

  2005cited by this paper
• New genotype-phenotype linkages for directed evolution of functional proteins.

  2005cited by this paper
• Engineered antibody fragments and the rise of single domains

  2005cited by this paper
• High-affinity binders selected from designed ankyrin repeat protein libraries

  2004cited by this paper
• Epratuzumab, a Humanized Anti-CD22 Antibody, in Aggressive Non-Hodgkin’s Lymphoma

  2004cited by this paper
• Stability improvement of antibodies for extracellular and intracellular applications: CDR grafting to stable frameworks and structure-based framework engineering.

  2004cited by this paper
• Treatment with monoclonal antibodies in acute lymphoblastic leukemia: current knowledge and future prospects

  2004cited by this paper
• Construction of phage display libraries from reactive lymph nodes of breast carcinoma patients and selection for specifically binding human single chain Fv on cell lines.

  2004cited by this paper
• Treatment of SCID/human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins

  2003cited by this paper
• CD22 as a target of passive immunotherapy.

  2003cited by this paper
• Panning and selection of proteins using ribosome display.

  2001cited by this paper
• Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia.

  2000cited by this paper
• Comparison of Escherichia coli and rabbit reticulocyte ribosome display systems

  1999cited by this paper
• Expression and structure of CD22 in acute leukemia.

  1988cited by this paper

• Eukaryotic ribosome display for antibody discovery: A review

  2024cites this paper
• Production of a Ribosome-Displayed Mouse scFv Antibody Against CD133, Analysis of Its Molecular Docking, and Molecular Dynamic Simulations of Their Interactions

  2023cites this paper
• Development of a novel anti-HER2 scFv by ribosome display and in silico evaluation of its 3D structure and interaction with HER2, alone and after fusion to LAMP2B

  2018cites this paper
• Ribosome display and selection of single‐chain variable fragments effectively inhibit growth and progression of microspheres in vitro and in vivo

  2018cites this paper
• Immobilization of antibodies on cardiovascular stents

  2018cites this paper
• Adding Functions to Biomaterial Surfaces through Protein Incorporation

  2016cites this paper
• Characterization of Anti-Citrinin Specific ScFvs Selected from Non-Immunized Mouse Splenocytes by Eukaryotic Ribosome Display

  2015cites this paper
• Selection of anti-cancer-associated gene single-chain variable fragments derived from gastric cancer patients using ribosome display.

  2013cites this paper
• Peptides de liaison à cd22

  2013cites this paper
• Selection and identification of a new adhesion protein of Cryptosporidium parvum from a cDNA library by ribosome display.

  2011cites this paper
• Preparation of Human Antibody Fragments Against Rabies Virus Based on Ribosome Display Technology*: Preparation of Human Antibody Fragments Against Rabies Virus Based on Ribosome Display Technology*

  2011cites this paper
• Biotechnology techniques for the development of new tumor specific peptides.

  2011cites this paper
• Selection and affinity maturation of human antibodies against rabies virus from a scFv gene library using ribosome display.

  2009cites this paper
• Anticorps monoclonaux humains spécifiques pour cd22

  2009cites this paper
• Selection of Anti-Sulfadimidine Specific ScFvs from a Hybridoma Cell by Eukaryotic Ribosome Display

  2009influential citation
• Grading the commercial optical biosensor literature—Class of 2008: ‘The Mighty Binders’

  2009cites this paper